Lakefront Biotherapeutics (LKFT) Gross Margin (QoQ) (2021 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Gross Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -105.00 |
| Mar 31, 2026 | 322,369.00 |
| Dec 31, 2025 | -328,244.00 |
| Sep 30, 2025 | -815.00 |
| Jun 30, 2025 | 1,116.00 |
| Mar 31, 2025 | -1,378.00 |
| Dec 31, 2024 | 597.00 |
| Sep 30, 2024 | -837.00 |
| Jun 30, 2024 | 195.00 |
| Mar 31, 2024 | -77.00 |
| Dec 31, 2023 | 607.00 |
| Sep 30, 2023 | -234.00 |
| Jun 30, 2023 | -95.00 |
| Mar 31, 2023 | -855.00 |
| Dec 31, 2022 | 424.00 |
| Sep 30, 2022 | 9.00 |
| Jun 30, 2022 | 26.00 |
| Mar 31, 2022 | -325.00 |
| Dec 31, 2021 | 133.00 |
| Sep 30, 2021 | -18.00 |